Your browser doesn't support javascript.
loading
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome.
Pengo, Vittorio; Denas, Gentian; Zoppellaro, Giacomo; Jose, Seena Padayattil; Hoxha, Ariela; Ruffatti, Amelia; Andreoli, Laura; Tincani, Angela; Cenci, Caterina; Prisco, Domenico; Fierro, Tiziana; Gresele, Paolo; Cafolla, Arturo; De Micheli, Valeria; Ghirarduzzi, Angelo; Tosetto, Alberto; Falanga, Anna; Martinelli, Ida; Testa, Sophie; Barcellona, Doris; Gerosa, Maria; Banzato, Alessandra.
Afiliação
  • Pengo V; Cardiology Clinic, Thrombosis Centre, Department of Cardiac Thoracic and Vascular Sciences, and.
  • Denas G; Cardiology Clinic, Thrombosis Centre, Department of Cardiac Thoracic and Vascular Sciences, and.
  • Zoppellaro G; Cardiology Clinic, Thrombosis Centre, Department of Cardiac Thoracic and Vascular Sciences, and.
  • Jose SP; Cardiology Clinic, Thrombosis Centre, Department of Cardiac Thoracic and Vascular Sciences, and.
  • Hoxha A; Rheumatology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Ruffatti A; Rheumatology Unit, Department of Medicine, University of Padua, Padua, Italy.
  • Andreoli L; Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
  • Tincani A; Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
  • Cenci C; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Prisco D; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Fierro T; Section of Internal and Cardiovascular Medicine, Department of Medicine, University of Perugia, Perugia, Italy.
  • Gresele P; Section of Internal and Cardiovascular Medicine, Department of Medicine, University of Perugia, Perugia, Italy.
  • Cafolla A; Department of Cellular Biotechnologies and Hematology Thrombosis Centre, Sapienza University of Rome, Rome, Italy.
  • De Micheli V; Transfusion Medicine, District Hospital, Merate, Italy.
  • Ghirarduzzi A; Angiology Unit, Department of Internal Medicine, Santa Maria Nuova Hospital, Reggio Emilia, Italy.
  • Tosetto A; Hematology Department, San Bortolo Hospital, Vicenza, Italy.
  • Falanga A; Department of Immunohematology and Transfusion Medicine and Hemostasis and Thrombosis Center, Hospital Papa Giovanni XXIII, Bergamo, Italy.
  • Martinelli I; A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.
  • Testa S; Hemostasis and Thrombosis Center, Laboratory Medicine Department, Azienda Socio-Sanitaria Territoriale, Cremona, Italy.
  • Barcellona D; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy; and.
  • Gerosa M; Division of Rheumatology, Department of Clinical Sciences and Community Health, Ospedale Gaetano Pini, University of Milan, Milan, Italy.
  • Banzato A; Cardiology Clinic, Thrombosis Centre, Department of Cardiac Thoracic and Vascular Sciences, and.
Blood ; 132(13): 1365-1371, 2018 09 27.
Article em En | MEDLINE | ID: mdl-30002145
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tromboembolia / Varfarina / Síndrome Antifosfolipídica / Inibidores do Fator Xa / Rivaroxabana / Anticoagulantes Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tromboembolia / Varfarina / Síndrome Antifosfolipídica / Inibidores do Fator Xa / Rivaroxabana / Anticoagulantes Idioma: En Ano de publicação: 2018 Tipo de documento: Article